Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 741

1.

Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.

Betts CJ, Dearman RJ, Heylings JR, Kimber I, Basketter DA.

Contact Dermatitis. 2006 Sep;55(3):140-7.

PMID:
16918612
2.
3.

Skin sensitization testing in potency and risk assessment.

Kimber I, Basketter DA, Berthold K, Butler M, Garrigue JL, Lea L, Newsome C, Roggeband R, Steiling W, Stropp G, Waterman S, Wiemann C.

Toxicol Sci. 2001 Feb;59(2):198-208. Review.

PMID:
11158712
4.

Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.

Takeyoshi M, Noda S, Yamazaki S, Kakishima H, Yamasaki K, Kimber I.

J Appl Toxicol. 2004 Jan-Feb;24(1):77-81.

PMID:
14745850
5.

Contact allergenic potency: correlation of human and local lymph node assay data.

Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG.

Am J Contact Dermat. 2001 Sep;12(3):156-61.

PMID:
11526521
6.

Quantitative relationship between the local lymph node assay and human skin sensitization assays.

Schneider K, Akkan Z.

Regul Toxicol Pharmacol. 2004 Jun;39(3):245-55.

PMID:
15135206
7.

Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.

Dearman RJ, Betts CJ, Farr C, McLaughlin J, Berdasco N, Wiench K, Kimber I.

Contact Dermatitis. 2007 Oct;57(4):242-7.

PMID:
17868217
8.

The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.

Jowsey IR, Clapp CJ, Safford B, Gibbons BT, Basketter DA.

Cutan Ocul Toxicol. 2008;27(2):67-75. doi: 10.1080/15569520801904655.

PMID:
18568891
9.

Activity of human contact allergens in the murine local lymph node assay.

Ryan CA, Gerberick GF, Cruse LW, Basketter DA, Lea L, Blaikie L, Dearman RJ, Warbrick EV, Kimber I.

Contact Dermatitis. 2000 Aug;43(2):95-102.

PMID:
10945748
10.

Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.

Durand G, de Burlet G, Virat M, Nauman BD.

Contact Dermatitis. 2003 Sep;49(3):148-54.

PMID:
14678211
11.

Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.

Gerberick GF, Ryan CA, Dearman RJ, Kimber I.

Methods. 2007 Jan;41(1):54-60. Review.

PMID:
16938465
12.

Local lymph node assay: validation assessment for regulatory purposes.

Gerberick GF, Ryan CA, Kimber I, Dearman RJ, Lea LJ, Basketter DA.

Am J Contact Dermat. 2000 Mar;11(1):3-18. Review.

PMID:
10684384
13.

The local lymph node assay: past, present and future.

Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF.

Contact Dermatitis. 2002 Dec;47(6):315-28. Review.

PMID:
12581276
14.

Human potency predictions for aldehydes using the local lymph node assay.

Basketter DA, Wright ZM, Warbrick EV, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, White IR.

Contact Dermatitis. 2001 Aug;45(2):89-94.

PMID:
11553118
15.

The local lymph node assay and the assessment of relative potency: status of validation.

Basketter DA, Gerberick F, Kimber I.

Contact Dermatitis. 2007 Aug;57(2):70-5. Review.

PMID:
17627643
16.

Predictive identification of human skin sensitization thresholds.

Basketter DA, Clapp C, Jefferies D, Safford B, Ryan CA, Gerberick F, Dearman RJ, Kimber I.

Contact Dermatitis. 2005 Nov;53(5):260-7.

PMID:
16283904
17.

Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.

Hilton J, Dearman RJ, Harvey P, Evans P, Basketter DA, Kimber I.

Am J Contact Dermat. 1998 Mar;9(1):29-33.

PMID:
9471984
18.

Potency and risk assessment of a skin-sensitizing disperse dye using the local lymph node assay.

Betts CJ, Dearman RJ, Kimber I, Maibach HI.

Contact Dermatitis. 2005 May;52(5):268-72.

PMID:
15899000
19.

A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.

Basketter DA, Lea LJ, Dickens A, Briggs D, Pate I, Dearman RJ, Kimber I.

J Appl Toxicol. 1999 Jul-Aug;19(4):261-6.

PMID:
10439340
20.

Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations.

Warbrick EV, Dearman RJ, Lea LJ, Basketter DA, Kimber I.

J Appl Toxicol. 1999 Jul-Aug;19(4):255-60.

PMID:
10439339

Supplemental Content

Support Center